Fundraising Fox
/Companies
Sign in

Muna Therapeutics

Founded 2020 · 58 employees on LinkedIn · 4 known investors

Find your way into Muna Therapeutics

Sign up to see every warm intro you have to Muna Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Muna Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Muna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.

BiotechDeep TechHealthtechLongevity

Founders & leadership

Muna Therapeutics was founded in 2020 by Rita Balice-Gordon and Joachim Vilstrup.

RBRita Balice-Gordon
Rita Balice-GordonCo-founder · Chief Executive Officer2021–2026Rita Balice-Gordon holds a Ph.D. in neuroscience and previously served as Chief Executive Officer of Muna Therapeutics, a clinical-stage biotechnology company developing disease-modifying therapies for neurodegenerative diseases. She spent her earlier career as a Professor of Neuroscience at the University of Pennsylvania and held leadership positions at Sanofi and Pfizer in drug discovery and development for neurologic and pain disorders.
JVJoachim Vilstrup
Joachim VilstrupHead of Protein Chemistry and Structural Biology; scientific co-founderJoachim Vilstrup is a scientific co-founder and Senior Director at Muna Therapeutics, a biotechnology company focused on drug discovery, where he oversees early discovery and leads protein chemistry and structural biology. He has built and scaled discovery platforms covering target validation, assay development, high-throughput screening, hit-to-lead optimization, and structure-guided drug design, and previously co-founded and led drug discovery work across early-stage biotech and academia.
MDMichel Detheux
Michel DetheuxChief Executive Officer & Board DirectorMichel Detheux holds a Ph.D. in Biochemistry from Catholic University of Louvain and brings over 30 years of experience in biotechnology and life sciences, including prior roles as President and CEO of iTeos Therapeutics, Director at Ludwig Cancer Research, and various scientific positions at Ogeda. He joined Muna Therapeutics as CEO to develop therapeutics for neurodegenerative diseases.
AHAnders Hinsby
Anders HinsbyChief Operating Officer
NPNiels Plath
Niels PlathChief Scientific OfficerChief Scientific Officer of Muna Therapeutics, a biotechnology company focused on drug discovery and medicinal chemistry.
JBJakob Busch-Petersen
Jakob Busch-PetersenChief Development OfficerHe has five years of experience in drug discovery and medicinal chemistry, including prior roles as a medicinal chemist and project leader where his work contributed to one marketed drug and multiple compounds in clinical development.

Investors · 4

Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M

How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

V-Bio Ventureslisted by V-Bio VenturesSint-Denijs-Westrem (Gent) · $270K – $2.2M

How we know: V-Bio Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Muna Therapeutics went on to found or lead other companies.

Michel DetheuxChief Executive Officer & Board DirectorFounded iTeos TherapeuticsJoachim VilstrupHead of Protein Chemistry and Structural Biology; scientific co-founderFounded Draupnir Bio

In the news

Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer'sprnewswire.com · Jan 2026Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseasesprnewswire.com · Jul 2021

Frequently asked questions

What does Muna Therapeutics do?
Muna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.
Who founded Muna Therapeutics?
Muna Therapeutics was founded by Rita Balice-Gordon, Joachim Vilstrup in 2020.
Who are Muna Therapeutics's investors?
Muna Therapeutics's investors include Droia Ventures, Sanofi Ventures, Sofinnova Partners, V-Bio Ventures.